Lang W, Anderson RE, Perkins H, Grant RM, Lyman D, Winkelstein W, Royce R, Levy JA. Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. San Francisco Men’s Health study. JAMA. 257:326-330, 1987.

Grant RM, Wiley JA, Winkelstein W. The infectivity of the human immunodeficiency virus: estimates from a cohort of homosexual men. J. Inf. Dis. 156:189-193, 1987.

Grant RM, Staprans SI, McLure HM, Johnson RP, Feinberg MB. Viral evolution in sooty mangabeys and rhesus macaques. J. Med. Primatol. 24(4):181, 1995.

Grant RM, Piwowar EM, Katongole-Mbidde E, Muzawalu W, Rugera S, Abima J, Stramer S, Kataaha P, Jackson B. Comparison of Saliva and Serum for HIV-1 Antibody Testing in Uganda Using a Rapid Recombinant Assay. Clin. Diag. Lab. Immunol. 3(6):640-644, 1996.

McCune JM, Loftus R, Schmidt DK, Carroll P, Webster D, Swor-Yim LB, Francis IR, Gross BH, Grant RM. High Prevalence of Thymic Tissue in Adults with HIV-1 Infection. J. Clin. Invest. 101(11):2301-2308, 1998.

Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Hellmann NS, Bandrapalli NI, Digilio L, Branson B, Kahn JO. Sexual Transmission of an HIV-1 variant resistant to multiple reverse transcriptase and protease inhibitors. N. Engl. J. Med. 339(5):307-311, 1998.

Palacios E, Digilio L, McClure HM, Chen Z, Marx PA, Goldsmith MA, Grant RM. Parallel evolution of CCR5-null phenotypes in humans and in natural host of simian immunodeficiency virus. Current Biology. 8:943-946, 1998.

Kaur A, Grant RM, Means RE, McClure H, Feinberg M, Johnson RP. Diverse host response and outcomes following SIVmac239 infection in sooty mangabeys and rhesus macaques. J. Virol. 72(12): 9597-9611, 1998.

Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy. AIDS 13 (6): F35-F43, 1999.

Deeks S and Grant RM. Sustained CD4 responses after virological failure of protease inhibitor-containing therapy. Antiviral Therapy. 4 (supplement 3):7-11, 1999.

Deeks S, Barbour JD, Martin JN, Swanson MS, Grant RM. Sustained CD4 T cell responses after virologic failure of protease inhibitor based regimens in HIV infected patients. JID 181:946-53, 2000.

Blower SM, Gershengorn HB, and Grant RM. A Tale of Two Futures: HIV and Anti-Retroviral Therapy in San Francisco. Science, 287, 650-654, 2000.

Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, Hellmann NS, Petropoulos CJ, McCune JM, Hellerstein MK, Grant RM. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N Engl J Med. 344 (7): 472-480, 2001.

Penn ML, Myers M, Eckstein DA, Liegler TJ, Hayden M, Mammano F, Clavel F, Deeks SG, Grant RM, Goldsmith MA. Primary and recombinant HIV-1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues. AIDS Res and Hum Retrov. 17: 517-523, 2001.

Liegler TJ, Hayden MS, Lee KS, Thounaojam M, Deeks SG, Grant RM. Protease inhibitor resistant HIV-1 from patients with CD4 counts is cytopathic in activated CD4+ lymphocytes. AIDS. 15: 179-184, 2001.

Stoddart CA, Liegler TJ, Mammano F, Linquist-Stepps VD, Hayden MS, Deeks SG, Grant RM, Clavel F, McCune JM. Impaired replication of protease inhibitor-resistant HIV-1 in human thymus. Nature Medicine. 7: 712-718, 2001.

Deeks SG, Barbour JD, Grant RM, Martin JN. Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia. AIDS 2002;16:201-207.

Deeks SG, Ho R, Grant RM, et al. CD4+ T Cell Kinetics and Activation in Human Immunodeficiency Virus-Infected Patients Who Remain Viremic Despite Long-term Treatment with Protease Inhibitor-Based Therapy. JID 2002.

Deeks SG, Grant RM, Wrin R, Paxinos EE, Liegler T, Hoh R, Barbour JD, Hellerstein M, Petropoulos CJ. Response to Antiretroviral Therapy after a Structured Treatment Interruption in Patients with Drug-Resistant HIV-1. Submitted.

Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, Petropoulos CJ, Hellmann NS, Chesney M, Busch MP, Kahn JO. Time trends in primary HIV-1 drug resistance among persons recently infected in San Francisco. JAMA. 288(2), 181-188, 2002.

Grant RM, Kuritzkes DR, Johnson V, Mellors JW, Sullivan JL, Swanstrom R, D’Aquila R, Van Gorter M, Holodniy M, Lloyd RM, Reid C, Morgan G, Winslow, DL. Accuracy of the TRUGENE HIV-1 genotyping kit. Submitted.

Kuritzkes DR, Grant RM, Feorino P, Griswold M, Hoover M, Young R, Day S, Lloyd R, Reid C, Morgan G, Winslow DL. Performance characteristics of the TRUGENE HIV-1 genotyping kit and OPENGENE DNA sequencing system. Submitted.